These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 8616985)

  • 21. Oral administration of micronized progesterone: a review and more experience.
    McAuley JW; Kroboth FJ; Kroboth PD
    Pharmacotherapy; 1996; 16(3):453-7. PubMed ID: 8726605
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Progesterone and preterm birth.
    Riskin-Mashiah S
    Am J Obstet Gynecol; 2004 Jun; 190(6):1802-3; author reply 1803-4. PubMed ID: 15290822
    [No Abstract]   [Full Text] [Related]  

  • 23. [Progesterone--medical preparation or commerce?].
    Iversen OE
    Tidsskr Nor Laegeforen; 2001 Dec; 121(30):3658. PubMed ID: 11808036
    [No Abstract]   [Full Text] [Related]  

  • 24. Supplemental progesterone to prevent preterm birth.
    O'Shaughnessy RW; Shaffer LE
    Am J Obstet Gynecol; 2004 Jun; 190(6):1800-1; author reply 1801-2. PubMed ID: 15290821
    [No Abstract]   [Full Text] [Related]  

  • 25. Cryopreserved-thawed embryo transfer in natural or down-regulated hormonally controlled cycles: a retrospective study.
    Gelbaya TA; Nardo LG; Hunter HR; Fitzgerald CT; Horne G; Pease EE; Brison DR; Lieberman BA
    Fertil Steril; 2006 Mar; 85(3):603-9. PubMed ID: 16500326
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Endometrial effects, bleeding control, and compliance with a new postmenopausal hormone therapy regimen based on transdermal estradiol gel and every-other-day vaginal progesterone in capsules: a 3-year pilot study.
    Cicinelli E; de Ziegler D; Alfonso R; Nicoletti R; Bellavia M; Colafiglio G
    Fertil Steril; 2005 Jun; 83(6):1859-63. PubMed ID: 15950667
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Vaginal micronized progesterone in continuous hormone replacement therapy. A prospective randomized study.
    Ferrero S; Gerbaldo D; Fulcheri E; Cristoforoni P
    Minerva Ginecol; 2002 Dec; 54(6):519-30. PubMed ID: 12432337
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Progesterone and preterm birth.
    Einstein FH; Bracero LA
    Am J Obstet Gynecol; 2004 Jun; 190(6):1798-9; author reply 1801-2. PubMed ID: 15290819
    [No Abstract]   [Full Text] [Related]  

  • 29. Prophylactic progesterone to prevent preterm birth.
    Tita AT; O'Day MP
    Am J Obstet Gynecol; 2004 Jun; 190(6):1799-800; author reply 1801-2. PubMed ID: 15290820
    [No Abstract]   [Full Text] [Related]  

  • 30. Progesterone: review of safety for clinical studies.
    Goletiani NV; Keith DR; Gorsky SJ
    Exp Clin Psychopharmacol; 2007 Oct; 15(5):427-44. PubMed ID: 17924777
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [A study of two different routes of administration of micronized progesterone in assisted reproduction].
    Gallardo Lozano E; Ayón P; Neuspiller F
    Ginecol Obstet Mex; 2004 Aug; 72():407-10. PubMed ID: 15526557
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Associations of histories of depression and PMDD diagnosis with allopregnanolone concentrations following the oral administration of micronized progesterone.
    Klatzkin RR; Morrow AL; Light KC; Pedersen CA; Girdler SS
    Psychoneuroendocrinology; 2006 Nov; 31(10):1208-19. PubMed ID: 17046166
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Does pre-treatment with micronized progesterone affect the ovarian response to a gonadotropin releasing hormone agonist flare-up protocol?
    Loutradis D; Stefanidis K; Drakakis P; Kallianidis K; El Sheikh A; Milingos S; Siskos K; Michalas S
    Gynecol Endocrinol; 2003 Apr; 17(2):101-6. PubMed ID: 12737670
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Endometrial morphology during hormone replacement therapy with estradiol gel combined to levonorgestrel-releasing intrauterine device or natural progesterone.
    Suvanto-Luukkonen E; Malinen H; Sundström H; Penttinen J; Kauppila A
    Acta Obstet Gynecol Scand; 1998 Aug; 77(7):758-63. PubMed ID: 9740525
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Arresting premature labour: orciprenaline and other drugs.
    Drug Ther Bull; 1973 Mar; 11(7):25-7. PubMed ID: 4580877
    [No Abstract]   [Full Text] [Related]  

  • 36. Nasal delivery progesterone powder formulations comparison with oral administration.
    Provasi D; De Ascentiis A; Minutello A; Colombo P; Catellani PL
    Boll Chim Farm; 1993 Nov; 132(10):402-4. PubMed ID: 8054196
    [No Abstract]   [Full Text] [Related]  

  • 37. Progestational agents.
    Br Med J; 1969 Aug; 3(5666):344-6. PubMed ID: 5816498
    [No Abstract]   [Full Text] [Related]  

  • 38. Natural vaginal progesterone is associated with minimal psychological side effects: a preliminary study.
    Shantha S; Brooks-Gunn J; Locke RJ; Warren MP
    J Womens Health Gend Based Med; 2001 Dec; 10(10):991-7. PubMed ID: 11788109
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Modulating fertility outcome in assisted reproductive technologies by the use of dydrogesterone.
    Patki A; Pawar VC
    Gynecol Endocrinol; 2007 Oct; 23 Suppl 1():68-72. PubMed ID: 17943542
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacokinetics of progesterone administered by the oral and parenteral routes.
    Stanczyk FZ
    J Reprod Med; 1999 Feb; 44(2 Suppl):141-7. PubMed ID: 11392023
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.